Low Testosterone Therapy Lawsuits

Low Testosterone Therapy Lawsuit Attorneys

Lawyers for Low T Therapy Claims

Because testosterone levels in men gradually decline with age, companies such as AbbVie and Eli Lilly & Co. manufacture and market products to boost or replace testosterone. “Low T” drugs refers to the drugs that replace or boost testosterone in men. Products such as AndroGel, Androderm, and Axiron currently face more than 6000 testosterone lawsuits in the testosterone multidistrict litigation because drugs used for testosterone therapy have been linked to serious side effects such as blood clots, stroke, and heart attacks. If you have suffered these types of injuries after taking low testosterone therapy drugs, call Simmons and Fletcher, P.C. for a free consultation regarding your potential claim. (713) 932-0777.

AndroGel, Androderm, and Axiron

AndroGel, currently manufactured by AbbVie’s parent company Abbott Laboratories, is one of the most prescribed gel medicines to treat low testosterone levels. After spending close to $80 million on marketing campaigns for AndroGel, AbbVie faces a growing number of lawsuits by men who suffered severe cardiac side effects. Axiron is a similar gel manufactured by Eli Lilly & Co. and has also been named in lawsuits over adverse side effects. Androderm is a testosterone transdermal patch manufactured by Actavis Inc., which was approved by the FDA in 1990. The purpose of a testosterone patch is to deliver testosterone continuously for 24 hours.

What are the Low T Therapy Lawsuits About?

While Low T therapy is intended to increase strength, sex drive, and vitality in men; it can also cause severe cardiac effects such as blood clots and heart attacks. It wasn’t until 2015 that the FDA announced labeling changes for all prescription testosterone products to state the increased risk of heart attacks and strokes. Today thousands of men suffer from injuries caused byproducts such as AndroGel, Androderm, and Axiron.

Bellwether Trials Continue for Low T Drugs

In January 2018, the sixth and final bellwether trial for AbbVie’s AndroGel is expected to begin. The second bellwether trial, which began July 2017, ended in a $150 million verdict against the manufacturer after Jeffrey Konrad suffered a heart attack just months after taking AndroGel. The plaintiffs suing AbbVie claim that the manufacturer failed to warn patients and doctors about the increased risk of cardiac effects caused by Low T drugs.

Low Testosterone Therapy Lawsuit Attorneys

If you or a loved one has suffered from severe side effects after using AndroGel, Androderm, or Axiron, you may be entitled to damages. Simmons and Fletcher, P.C. is dedicated to helping these men find justice for any injuries they may have sustained while seeking medical treatment. Call us today to set up a free Low T consultation: (713) 932-0777.